NEW YORK (GenomeWeb) — Karius announced today that it has signed an agreement to launch its next-generation sequencing-based infectious disease test in Brazil with medical diagnostics firm Dasa.
The recently launched test can detect over 1,000 pathogens — including bacteria, DNA viruses, fungi, mold, and protozoa — from microbial cell-free DNA in a single blood draw.